Kangdi Zhu1, Jacobus J van Hilten1, Johan Marinus2. 1. Department of Neurology, Leiden University Medical Center, Leiden, The Netherlands. 2. Department of Neurology, Leiden University Medical Center, Leiden, The Netherlands. Electronic address: j.marinus@lumc.nl.
Abstract
OBJECTIVE: Aim of this study was to identify risk factors for the development of dementia in patients with Parkinson's disease (PD). METHODS: A broad range of motor and non-motor features was assessed at baseline and the following five years in 406 PD patients. Cross-sectional analyses of baseline data and longitudinal analyses of follow-up data were performed to identify risk factors for dementia. RESULTS: Thirty-two percent of patients (n = 129) had dementia at baseline, while 26% of patients (n = 68) without dementia at baseline developed dementia during follow-up. Univariate survival analysis showed that higher age, fewer years of education, longer disease duration, higher age-at-onset, higher levodopa dose, higher Hoehn & Yahr stage, presence of dyskinesias, excessive daytime sleepiness (EDS), presence of hallucinations, and more severe autonomic and depressive symptoms were associated with an increased risk of dementia. Higher baseline Postural-Instability-and-Gait-Difficulty scores were also associated with an increased risk of dementia, whereas no effect of tremor severity was found. These findings largely corresponded with the variables that were associated with the presence of dementia at baseline. In a stepwise regression model, higher age at baseline, fewer years of education, higher daily levodopa dose and excessive daytime sleepiness (EDS) emerged as independent risk factors of future dementia. CONCLUSIONS: In this large prospective cohort study, we identified a combination of potentially interacting risk factors for dementia in PD that are associated with higher age and more advanced disease.
OBJECTIVE: Aim of this study was to identify risk factors for the development of dementia in patients with Parkinson's disease (PD). METHODS: A broad range of motor and non-motor features was assessed at baseline and the following five years in 406 PDpatients. Cross-sectional analyses of baseline data and longitudinal analyses of follow-up data were performed to identify risk factors for dementia. RESULTS: Thirty-two percent of patients (n = 129) had dementia at baseline, while 26% of patients (n = 68) without dementia at baseline developed dementia during follow-up. Univariate survival analysis showed that higher age, fewer years of education, longer disease duration, higher age-at-onset, higher levodopa dose, higher Hoehn & Yahr stage, presence of dyskinesias, excessive daytime sleepiness (EDS), presence of hallucinations, and more severe autonomic and depressive symptoms were associated with an increased risk of dementia. Higher baseline Postural-Instability-and-Gait-Difficulty scores were also associated with an increased risk of dementia, whereas no effect of tremor severity was found. These findings largely corresponded with the variables that were associated with the presence of dementia at baseline. In a stepwise regression model, higher age at baseline, fewer years of education, higher daily levodopa dose and excessive daytime sleepiness (EDS) emerged as independent risk factors of future dementia. CONCLUSIONS: In this large prospective cohort study, we identified a combination of potentially interacting risk factors for dementia in PD that are associated with higher age and more advanced disease.
Authors: Ganqiang Liu; Joseph J Locascio; Jean-Christophe Corvol; Brendon Boot; Zhixiang Liao; Kara Page; Daly Franco; Kyle Burke; Iris E Jansen; Ana Trisini-Lipsanopoulos; Sophie Winder-Rhodes; Caroline M Tanner; Anthony E Lang; Shirley Eberly; Alexis Elbaz; Alexis Brice; Graziella Mangone; Bernard Ravina; Ira Shoulson; Florence Cormier-Dequaire; Peter Heutink; Jacobus J van Hilten; Roger A Barker; Caroline H Williams-Gray; Johan Marinus; Clemens R Scherzer Journal: Lancet Neurol Date: 2017-06-16 Impact factor: 44.182
Authors: Anne-Marie A Wills; Jordan J Elm; Rong Ye; Kelvin L Chou; Sotirios A Parashos; Robert A Hauser; Ivan Bodis-Wollner; Vanessa K Hinson; Chadwick W Christine; Jay S Schneider Journal: Parkinsonism Relat Disord Date: 2016-10-08 Impact factor: 4.891
Authors: Wojciech Gryc; Kathryn A Roberts; Cyrus P Zabetian; Daniel Weintraub; John Q Trojanowski; Joseph F Quinn; Amie L Hiller; Kathryn A Chung; Kathleen L Poston; Laurice Yang; Shu-Ching Hu; Karen L Edwards; Thomas J Montine; Brenna A Cholerton Journal: J Parkinsons Dis Date: 2020 Impact factor: 5.568
Authors: Benjamin K Dawson; Seyed-Mohammad Fereshtehnejad; Julius B M Anang; Takashi Nomura; Silvia Rios-Romenets; Kenji Nakashima; Jean-François Gagnon; Ronald B Postuma Journal: JAMA Neurol Date: 2018-06-01 Impact factor: 18.302